Page last updated: 2024-11-05

triamterene and Hypertension, Malignant

triamterene has been researched along with Hypertension, Malignant in 2 studies

Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.

Hypertension, Malignant: A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SINGER, MM1
HOFF, HR1
FISCH, S1
DEGRAFF, AC1
Hagino, K1

Other Studies

2 other studies available for triamterene and Hypertension, Malignant

ArticleYear
RED BLOOD CELL POTASSIUM; THERAPEUTIC IMPLICATIONS.
    JAMA, 1964, Jan-04, Volume: 187

    Topics: Anemia; Anemia, Hypochromic; Blood Platelets; Digitalis Glycosides; Diuretics; Erythrocytes; Fludroc

1964
[Hypertension--malignant hypertension].
    Naika. Internal medicine, 1971, Volume: 27, Issue:6

    Topics: Diuretics; Hexamethonium Compounds; Humans; Hydrazines; Hypertension, Malignant; Male; Methyldopa; M

1971